Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size, Status and Forecast 2020-2026

July 2020 | 97 pages | ID: G00DD530E846EN
QYResearch

Abstracts

This report focuses on the global Taditional Chinese Medicine (TCM) for COVID-19 status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Taditional Chinese Medicine (TCM) for COVID-19 development in China..

The key players covered in this study

• Yiling Pharmaceutical
• Tianjin Chase Sun Pharmaceutical
• Sunflower
• Guizhou Yibai Pharmaceutical
• Beijing Juxiechang Pharmaceutical
• Jiren Pharmaceutical Group
• Qingfeng Pharmaceutical Group
• Southwest Pharmaceutical
• Jiuzhitang
• China Beijing Tong Ren Tang Group Co., Ltd.
• Jiangsu Jichuan Holding Group Co., Ltd.

Market segment by Type, the product can be split into

• Lianhua Qingwen Capsule
• Jinhua Qinggan Granules
• Xuebijing Injection
• TCM Prescription
• Other

Market segment by Application, split into

• Hospital
• Clinic
• Other

Market segment by Regions/Countries, this report covers

• China

The study objectives of this report are:

• To analyze global Taditional Chinese Medicine (TCM) for COVID-19 status, future forecast, growth opportunity, key market and key players.
• To present the Taditional Chinese Medicine (TCM) for COVID-19 development in China..

To strategically profile the key players and comprehensively analyze their development plan and strategies.

• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Taditional Chinese Medicine (TCM) for COVID-19 are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Taditional Chinese Medicine (TCM) for COVID-19 Revenue
1.4 Covid-19 Implications on Market by Type
  1.4.1 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Lianhua Qingwen Capsule
  1.4.3 Jinhua Qinggan Granules
  1.4.4 Xuebijing Injection
  1.4.5 TCM Prescription
  1.4.6 Other
1.5 Covid-19 Implications on Market by Application
  1.5.1 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Taditional Chinese Medicine (TCM) for COVID-19 Industry Impact
  1.6.1 How the Covid-19 is Affecting the Taditional Chinese Medicine (TCM) for COVID-19 Industry
    1.6.1.1 Taditional Chinese Medicine (TCM) for COVID-19 Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Taditional Chinese Medicine (TCM) for COVID-19 Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Taditional Chinese Medicine (TCM) for COVID-19 Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Covid-19 Implications on Global Taditional Chinese Medicine (TCM) for COVID-19 Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Taditional Chinese Medicine (TCM) for COVID-19 Growth Trends by Regions
  2.2.1 Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Taditional Chinese Medicine (TCM) for COVID-19 Historic Market Share by Regions (2015-2020)
  2.2.3 Taditional Chinese Medicine (TCM) for COVID-19 Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Taditional Chinese Medicine (TCM) for COVID-19 Market Growth Strategy
  2.3.6 Primary Interviews with Key Taditional Chinese Medicine (TCM) for COVID-19 Players (Opinion Leaders)

3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Taditional Chinese Medicine (TCM) for COVID-19 Players by Market Size
  3.1.1 Global Top Taditional Chinese Medicine (TCM) for COVID-19 Players by Revenue (2015-2020)
  3.1.2 Global Taditional Chinese Medicine (TCM) for COVID-19 Revenue Market Share by Players (2015-2020)
  3.1.3 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Concentration Ratio
  3.2.1 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Taditional Chinese Medicine (TCM) for COVID-19 Revenue in 2019
3.3 Taditional Chinese Medicine (TCM) for COVID-19 Key Players Head office and Area Served
3.4 Key Players Taditional Chinese Medicine (TCM) for COVID-19 Product Solution and Service
3.5 Date of Enter into Taditional Chinese Medicine (TCM) for COVID-19 Market
3.6 Mergers & Acquisitions, Expansion Plans

4 COVID-19 IMPLICATIONS ON MARKET SIZE BY TYPE (2015-2026)

4.1 Global Taditional Chinese Medicine (TCM) for COVID-19 Historic Market Size by Type (2015-2020)
4.2 Global Taditional Chinese Medicine (TCM) for COVID-19 Forecasted Market Size by Type (2021-2026)

5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Application (2015-2020)
5.2 Global Taditional Chinese Medicine (TCM) for COVID-19 Forecasted Market Size by Application (2021-2026)

6 CHINA

6.1 China Taditional Chinese Medicine (TCM) for COVID-19 Market Size (2015-2020)
6.2 Taditional Chinese Medicine (TCM) for COVID-19 Key Players in China (2019-2020)
6.3 China Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Type (2015-2020)
6.4 China Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)
(2015-2020)
(2015-2020)
(2015-2020)
(2015-2020)

7KEY PLAYERS PROFILES

7.1 Yiling Pharmaceutical
  7.1.1 Yiling Pharmaceutical Company Details
  7.1.2 Yiling Pharmaceutical Business Overview and Its Total Revenue
  7.1.3 Yiling Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Introduction
  7.1.4 Yiling Pharmaceutical Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020))
  7.1.5 Yiling Pharmaceutical Recent Development
7.2 Tianjin Chase Sun Pharmaceutical
  7.2.1 Tianjin Chase Sun Pharmaceutical Company Details
  7.2.2 Tianjin Chase Sun Pharmaceutical Business Overview and Its Total Revenue
  7.2.3 Tianjin Chase Sun Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Introduction
  7.2.4 Tianjin Chase Sun Pharmaceutical Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020)
  7.2.5 Tianjin Chase Sun Pharmaceutical Recent Development
7.3 Sunflower
  7.3.1 Sunflower Company Details
  7.3.2 Sunflower Business Overview and Its Total Revenue
  7.3.3 Sunflower Taditional Chinese Medicine (TCM) for COVID-19 Introduction
  7.3.4 Sunflower Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020)
  7.3.5 Sunflower Recent Development
7.4 Guizhou Yibai Pharmaceutical
  7.4.1 Guizhou Yibai Pharmaceutical Company Details
  7.4.2 Guizhou Yibai Pharmaceutical Business Overview and Its Total Revenue
  7.4.3 Guizhou Yibai Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Introduction
  7.4.4 Guizhou Yibai Pharmaceutical Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020)
  7.4.5 Guizhou Yibai Pharmaceutical Recent Development
7.5 Beijing Juxiechang Pharmaceutical
  7.5.1 Beijing Juxiechang Pharmaceutical Company Details
  7.5.2 Beijing Juxiechang Pharmaceutical Business Overview and Its Total Revenue
  7.5.3 Beijing Juxiechang Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Introduction
  7.5.4 Beijing Juxiechang Pharmaceutical Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020)
  7.5.5 Beijing Juxiechang Pharmaceutical Recent Development
7.6 Jiren Pharmaceutical Group
  7.6.1 Jiren Pharmaceutical Group Company Details
  7.6.2 Jiren Pharmaceutical Group Business Overview and Its Total Revenue
  7.6.3 Jiren Pharmaceutical Group Taditional Chinese Medicine (TCM) for COVID-19 Introduction
  7.6.4 Jiren Pharmaceutical Group Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020)
  7.6.5 Jiren Pharmaceutical Group Recent Development
7.7 Qingfeng Pharmaceutical Group
  7.7.1 Qingfeng Pharmaceutical Group Company Details
  7.7.2 Qingfeng Pharmaceutical Group Business Overview and Its Total Revenue
  7.7.3 Qingfeng Pharmaceutical Group Taditional Chinese Medicine (TCM) for COVID-19 Introduction
  7.7.4 Qingfeng Pharmaceutical Group Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020)
  7.7.5 Qingfeng Pharmaceutical Group Recent Development
7.8 Southwest Pharmaceutical
  7.8.1 Southwest Pharmaceutical Company Details
  7.8.2 Southwest Pharmaceutical Business Overview and Its Total Revenue
  7.8.3 Southwest Pharmaceutical Taditional Chinese Medicine (TCM) for COVID-19 Introduction
  7.8.4 Southwest Pharmaceutical Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020)
  7.8.5 Southwest Pharmaceutical Recent Development
7.9 Jiuzhitang
  7.9.1 Jiuzhitang Company Details
  7.9.2 Jiuzhitang Business Overview and Its Total Revenue
  7.9.3 Jiuzhitang Taditional Chinese Medicine (TCM) for COVID-19 Introduction
  7.9.4 Jiuzhitang Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020)
  7.9.5 Jiuzhitang Recent Development
7.10 China Beijing Tong Ren Tang Group Co., Ltd.
  7.10.1 China Beijing Tong Ren Tang Group Co., Ltd. Company Details
  7.10.2 China Beijing Tong Ren Tang Group Co., Ltd. Business Overview and Its Total Revenue
  7.10.3 China Beijing Tong Ren Tang Group Co., Ltd. Taditional Chinese Medicine (TCM) for COVID-19 Introduction
  7.10.4 China Beijing Tong Ren Tang Group Co., Ltd. Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020)
  7.10.5 China Beijing Tong Ren Tang Group Co., Ltd. Recent Development
7.11 Jiangsu Jichuan Holding Group Co., Ltd.
  10.11.1 Jiangsu Jichuan Holding Group Co., Ltd. Company Details
  10.11.2 Jiangsu Jichuan Holding Group Co., Ltd. Business Overview and Its Total Revenue
  10.11.3 Jiangsu Jichuan Holding Group Co., Ltd. Taditional Chinese Medicine (TCM) for COVID-19 Introduction
  10.11.4 Jiangsu Jichuan Holding Group Co., Ltd. Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020)
  10.11.5 Jiangsu Jichuan Holding Group Co., Ltd. Recent Development

8ANALYST'S VIEWPOINTS/CONCLUSIONS

9APPENDIX

9.1 Research Methodology
  9.1.1 Methodology/Research Approach
  9.1.2 Data Source
9.2 Disclaimer
9.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Taditional Chinese Medicine (TCM) for COVID-19 Key Market Segments
Table 2. Key Players Covered: Ranking by Taditional Chinese Medicine (TCM) for COVID-19 Revenue
Table 3. Ranking of Global Top Taditional Chinese Medicine (TCM) for COVID-19 Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Lianhua Qingwen Capsule
Table 6. Key Players of Jinhua Qinggan Granules
Table 7. Key Players of Xuebijing Injection
Table 8. Key Players of TCM Prescription
Table 9. Key Players of Other
Table 10. COVID-19 Impact Global Market: (Four Taditional Chinese Medicine (TCM) for COVID-19 Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Taditional Chinese Medicine (TCM) for COVID-19 Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Taditional Chinese Medicine (TCM) for COVID-19 Players to Combat Covid-19 Impact
Table 15. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Regions (2015-2020)
Table 19. Global Taditional Chinese Medicine (TCM) for COVID-19 Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Taditional Chinese Medicine (TCM) for COVID-19 Market Growth Strategy
Table 25. Main Points Interviewed from Key Taditional Chinese Medicine (TCM) for COVID-19 Players
Table 26. Global Taditional Chinese Medicine (TCM) for COVID-19 Revenue by Players (2015-2020) (Million US$)
Table 27. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Players (2015-2020)
Table 28. Global Top Taditional Chinese Medicine (TCM) for COVID-19 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Taditional Chinese Medicine (TCM) for COVID-19 as of 2019)
Table 29. Global Taditional Chinese Medicine (TCM) for COVID-19 by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Taditional Chinese Medicine (TCM) for COVID-19 Product Solution and Service
Table 32. Date of Enter into Taditional Chinese Medicine (TCM) for COVID-19 Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Type (2015-2020) (Million US$)
Table 35. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size Share by Type (2015-2020)
Table 36. Global Taditional Chinese Medicine (TCM) for COVID-19 Revenue Market Share by Type (2021-2026)
Table 37. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size Share by Application (2015-2020)
Table 38. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Application (2015-2020) (Million US$)
Table 39. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size Share by Application (2021-2026)
Table 40. China Key Players Taditional Chinese Medicine (TCM) for COVID-19 Revenue (2019-2020) (Million US$)
Table 41. China Key Players Taditional Chinese Medicine (TCM) for COVID-19 Market Share (2019-2020)
Table 42. China Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Type (2015-2020) (Million US$)
Table 43. China Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Type (2015-2020)
Table 44. China Taditional Chinese Medicine (TCM) for COVID-19 Market Size by Application (2015-2020) (Million US$)
Table 45. China Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Application (2015-2020)
Table 46. Yiling Pharmaceutical Company Details
Table 47. Yiling Pharmaceutical Business Overview
Table 48. Yiling Pharmaceutical Product
Table 49. Yiling Pharmaceutical Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020) (Million US$)
Table 50. Yiling Pharmaceutical Recent Development
Table 51. Tianjin Chase Sun Pharmaceutical Company Details
Table 52. Tianjin Chase Sun Pharmaceutical Business Overview
Table 53. Tianjin Chase Sun Pharmaceutical Product
Table 54. Tianjin Chase Sun Pharmaceutical Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020) (Million US$)
Table 55. Tianjin Chase Sun Pharmaceutical Recent Development
Table 56. Sunflower Company Details
Table 57. Sunflower Business Overview
Table 58. Sunflower Product
Table 59. Sunflower Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020) (Million US$)
Table 60. Sunflower Recent Development
Table 61. Guizhou Yibai Pharmaceutical Company Details
Table 62. Guizhou Yibai Pharmaceutical Business Overview
Table 63. Guizhou Yibai Pharmaceutical Product
Table 64. Guizhou Yibai Pharmaceutical Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020) (Million US$)
Table 65. Guizhou Yibai Pharmaceutical Recent Development
Table 66. Beijing Juxiechang Pharmaceutical Company Details
Table 67. Beijing Juxiechang Pharmaceutical Business Overview
Table 68. Beijing Juxiechang Pharmaceutical Product
Table 69. Beijing Juxiechang Pharmaceutical Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020) (Million US$)
Table 70. Beijing Juxiechang Pharmaceutical Recent Development
Table 71. Jiren Pharmaceutical Group Company Details
Table 72. Jiren Pharmaceutical Group Business Overview
Table 73. Jiren Pharmaceutical Group Product
Table 74. Jiren Pharmaceutical Group Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020) (Million US$)
Table 75. Jiren Pharmaceutical Group Recent Development
Table 76. Qingfeng Pharmaceutical Group Company Details
Table 77. Qingfeng Pharmaceutical Group Business Overview
Table 78. Qingfeng Pharmaceutical Group Product
Table 79. Qingfeng Pharmaceutical Group Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020) (Million US$)
Table 80. Qingfeng Pharmaceutical Group Recent Development
Table 81. Southwest Pharmaceutical Business Overview
Table 82. Southwest Pharmaceutical Product
Table 83. Southwest Pharmaceutical Company Details
Table 84. Southwest Pharmaceutical Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020) (Million US$)
Table 85. Southwest Pharmaceutical Recent Development
Table 86. Jiuzhitang Company Details
Table 87. Jiuzhitang Business Overview
Table 88. Jiuzhitang Product
Table 89. Jiuzhitang Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020) (Million US$)
Table 90. Jiuzhitang Recent Development
Table 91. China Beijing Tong Ren Tang Group Co., Ltd. Company Details
Table 92. China Beijing Tong Ren Tang Group Co., Ltd. Business Overview
Table 93. China Beijing Tong Ren Tang Group Co., Ltd. Product
Table 94. China Beijing Tong Ren Tang Group Co., Ltd. Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020) (Million US$)
Table 95. China Beijing Tong Ren Tang Group Co., Ltd. Recent Development
Table 96. Jiangsu Jichuan Holding Group Co., Ltd. Company Details
Table 97. Jiangsu Jichuan Holding Group Co., Ltd. Business Overview
Table 98. Jiangsu Jichuan Holding Group Co., Ltd. Product
Table 99. Jiangsu Jichuan Holding Group Co., Ltd. Revenue in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020) (Million US$)
Table 100. Jiangsu Jichuan Holding Group Co., Ltd. Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Type: 2020 VS 2026
Figure 2. Lianhua Qingwen Capsule Features
Figure 3. Jinhua Qinggan Granules Features
Figure 4. Xuebijing Injection Features
Figure 5. TCM Prescription Features
Figure 6. Other Features
Figure 7. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Application: 2020 VS 2026
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Other Case Studies
Figure 11. Taditional Chinese Medicine (TCM) for COVID-19 Report Years Considered
Figure 12. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Regions: 2020 VS 2026
Figure 14. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Taditional Chinese Medicine (TCM) for COVID-19 Market Share by Players in 2019
Figure 17. Global Top Taditional Chinese Medicine (TCM) for COVID-19 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Taditional Chinese Medicine (TCM) for COVID-19 as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Taditional Chinese Medicine (TCM) for COVID-19 Revenue in 2019
Figure 19. China Taditional Chinese Medicine (TCM) for COVID-19 Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Yiling Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 21. Yiling Pharmaceutical Revenue Growth Rate in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020)
Figure 22. Tianjin Chase Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Tianjin Chase Sun Pharmaceutical Revenue Growth Rate in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020)
Figure 24. Sunflower Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Sunflower Revenue Growth Rate in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020)
Figure 26. Guizhou Yibai Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Guizhou Yibai Pharmaceutical Revenue Growth Rate in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020)
Figure 28. Beijing Juxiechang Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Beijing Juxiechang Pharmaceutical Revenue Growth Rate in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020)
Figure 30. Jiren Pharmaceutical Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Jiren Pharmaceutical Group Revenue Growth Rate in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020)
Figure 32. Qingfeng Pharmaceutical Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Qingfeng Pharmaceutical Group Revenue Growth Rate in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020)
Figure 34. Southwest Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Southwest Pharmaceutical Revenue Growth Rate in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020)
Figure 36. Jiuzhitang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Jiuzhitang Revenue Growth Rate in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020)
Figure 38. China Beijing Tong Ren Tang Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. China Beijing Tong Ren Tang Group Co., Ltd. Revenue Growth Rate in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020)
Figure 40. Jiangsu Jichuan Holding Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Jiangsu Jichuan Holding Group Co., Ltd. Revenue Growth Rate in Taditional Chinese Medicine (TCM) for COVID-19 Business (2015-2020)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed